Sodium Channel Antagonists [MoA] - N0000181004

Pharmacologic Code	N0000181004
Pharmacologic Name	Sodium Channel Antagonists
Pharmacologic Uses	sodium channel blocker
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 6 products whose active ingredient are classified under the same pharmacologic class Sodium Channel Antagonists [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	51167-548	Journavx	Non-Proprietary Name: Suzetrigine	Tablet, Film Coated	Oral	Vertex Pharmaceuticals Incorporated	ACTIVE
	71699-025	Xcopri	Non-Proprietary Name: Cenobamate	Tablet, Film Coated	Oral	Sk Life Science, Inc.	ACTIVE
	71699-050	Xcopri	Non-Proprietary Name: Cenobamate	Tablet, Film Coated	Oral	Sk Life Science, Inc.	ACTIVE
	71699-100	Xcopri	Non-Proprietary Name: Cenobamate	Tablet, Film Coated	Oral	Sk Life Science, Inc.	ACTIVE
	71699-150	Xcopri	Non-Proprietary Name: Cenobamate	Tablet, Film Coated	Oral	Sk Life Science, Inc.	ACTIVE
	71699-200	Xcopri	Non-Proprietary Name: Cenobamate	Tablet, Film Coated	Oral	Sk Life Science, Inc.	ACTIVE